Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer.
Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer.
复制标题
巨噬细胞靶向有助于 Embelin 对结肠炎相关癌症的抑制作用。
DOI:
10.18632/oncotarget.6969
复制
发表时间:
2016-04-12
期刊:
影响因子:
--
通讯作者:
Qiao L
中科院分区:
文献类型:
--
作者:
Wu T;Dai Y;Wang W;Teng G;Jiao H;Shuai X;Zhang R;Zhao P;Qiao L
Macrophages are a major component of inflammatory and tumor microenvironment. We previously reported that embelin suppresses colitis-associated tumorigenesis. Here, the role of macrophage targeting in the anti-inflammatory and anti-tumor properties of embelin was investigated. By using colitis-associated cancer (CAC) model, we demonstrated that embelin significantly depleted colon macrophages by blocking their recruitment. Moreover, embelin attenuated M2-like polarization of macrophages within the tumor microenvironment and eliminated their tumor-promoting functions during the development of CAC. Embelin potently inhibited NF-κB signaling in macrophages and decreased the production of key pro-inflammatory cytokines and tumorigenic factors involved in CAC, such as TNFα, IL-6 and COX-2. In addition, embelin directly reduced the polarization of M2 macrophages in vitro even in the presence of Th2 cytokines. These results suggested that targeting macrophages is, at least in part, responsible for the anti-tumor activity of embelin in CAC. Our observations strengthen the rationale for future validation of embelin in the prevention and treatment of CAC